Impact of Type II LRRK2 inhibitors on signaling and mitophagy (2021)
Attributed to:
Understanding Signalling Pathways Mutated in Inherited Disorders
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1042/bcj20210375
PubMed Identifier: 34515301
Publication URI: http://europepmc.org/abstract/MED/34515301
Type: Journal Article/Review
Parent Publication: Biochemical Journal
Issue: 19
ISSN: 0264-6021